Heart failure genetics and molecular study
Part of Heart & circulation clinical trials.
This study looks at the biological causes of heart failure, including genes and other molecules, to better understand the disease. It may help researchers find new ways to treat heart failure in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with heart failure by a doctor.
- You understand the study and can provide written consent.
- You are willing to come back for follow-up visits.
- You do not have active cancer or a history of cancer with ongoing treatment.
- You do not have an autoimmune disease or a serious infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how genes affect heart failure treatment response. It uses blood samples to find new markers that may help predict who will benefit most from therapy.
This study is looking at people with any type of heart failure, whether it's stable and managed at home or newly diagnosed in the hospital. The goal is to learn more about how to improve care, no matter what your ejection fraction level is.
This study looks at the health outcomes of people with common heart conditions like coronary artery disease, high blood pressure, heart failure, or cardiomyopathy. It may help researchers understand how these conditions progress and how to better manage them.
This study looks at different types of heart failure to understand them better. You may join if you have active heart failure (with symptoms like shortness of breath or swelling) and are willing to participate in research activities.
This study looks at how your genes and immune system affect heart failure. Researchers want to understand why some people have flare-ups (exacerbations) and how the body responds.
This study looks at a new way to group and treat heart failure along with kidney, liver, and metabolic problems. It may help people with different stages of heart failure, including those with early signs.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.